Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus recommendations for clinical functional MRI applied to language mapping.

Aperture neuro·2026
Same author

MAPK-driven glioma progression and reprogramming of the tumor-associated immune response.

Neuro-oncology·2026
Same author

Human intracranial signal stability tracks anatomical accuracy after electrode reimplantation.

Journal of neural engineering·2026
Same author

Cerebrovascular vulnerability and fibrosis in human brain aneurysms.

Nature neuroscience·2026
Same author

Targeted Connectomic Neuromodulation of the Orbitofrontal Cortex To Treat Obsessive-Compulsive Disorder.

medRxiv : the preprint server for health sciences·2026
Same author

Opposing effects of slow and fast theta synchrony on working memory in the human hippocampal-orbitofrontal network.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Mar 29, 2026

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

1.1K

Stereotactic Laser Ablation for Hypothalamic Hamartoma.

John D Rolston1, Edward F Chang1

  • 1Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Ave., M779, San Francisco, CA 94143, USA.

Neurosurgery Clinics of North America
|November 29, 2015
PubMed
Summary

Stereotactic laser ablation offers a minimally invasive epilepsy treatment, potentially surpassing open surgery in seizure control. This advanced technique reduces side effects and hospital stays, improving patient access to care.

Keywords:
AblationGelastic seizuresHypothalamic hamartomaLaserRefractory epilepsyTechnical approach

More Related Videos

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
11:29

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study

Published on: August 15, 2025

3.0K
An Immunocompetent Murine Model for Laser Interstitial Thermal Therapy of Glioblastoma
09:10

An Immunocompetent Murine Model for Laser Interstitial Thermal Therapy of Glioblastoma

Published on: November 15, 2024

1.0K

Related Experiment Videos

Last Updated: Mar 29, 2026

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

1.1K
Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
11:29

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study

Published on: August 15, 2025

3.0K
An Immunocompetent Murine Model for Laser Interstitial Thermal Therapy of Glioblastoma
09:10

An Immunocompetent Murine Model for Laser Interstitial Thermal Therapy of Glioblastoma

Published on: November 15, 2024

1.0K

Area of Science:

  • Neurosurgery
  • Epilepsy Treatment
  • Minimally Invasive Procedures

Background:

  • Medication-resistant epilepsy requires effective treatment options.
  • Open resective surgery poses risks like neurocognitive and endocrine side effects.
  • Minimally invasive approaches are sought to improve epilepsy treatment outcomes.

Purpose of the Study:

  • To evaluate stereotactic laser ablation (SLA) as a treatment for medication-resistant epilepsy.
  • To compare the effectiveness and safety of SLA with traditional open resection.
  • To highlight the benefits of SLA in terms of patient outcomes and recovery.

Main Methods:

  • Utilizing stereotactic laser ablation (SLA) for targeted seizure focus destruction.
  • Employing real-time magnetic resonance thermal mapping for precise ablation.
  • Analyzing early clinical series data to assess seizure freedom rates and adverse effects.

Main Results:

  • Stereotactic laser ablation (SLA) demonstrates comparable or superior seizure freedom rates to open resection.
  • SLA significantly minimizes neurocognitive and endocrine adverse effects associated with epilepsy surgery.
  • Patients experience shorter hospital stays, no ICU requirement, and reduced discomfort.

Conclusions:

  • Stereotactic laser ablation (SLA) is a highly effective and safe minimally invasive treatment for medication-resistant epilepsy.
  • SLA offers significant advantages over open resection, including improved patient recovery and fewer side effects.
  • SLA expands surgical treatment accessibility for epilepsy patients.